IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,762,000 | -28.3% | 533,301 | -52.9% | 1.98% | -48.1% |
| Q3 2019 | $20,586,000 | -46.2% | 1,131,101 | -27.5% | 3.81% | -54.2% |
| Q2 2019 | $38,234,000 | -7.1% | 1,559,299 | -64.0% | 8.32% | -2.1% |
| Q1 2019 | $41,162,000 | -21.8% | 4,328,303 | -27.3% | 8.50% | +22.7% |
| Q4 2018 | $52,668,000 | -4.3% | 5,951,153 | +21.6% | 6.92% | -14.5% |
| Q3 2018 | $55,062,000 | +3.1% | 4,894,361 | +17.3% | 8.10% | -3.7% |
| Q2 2018 | $53,429,000 | +246.3% | 4,174,105 | +357.2% | 8.41% | +249.9% |
| Q1 2018 | $15,429,000 | -17.6% | 912,987 | -61.0% | 2.40% | -21.5% |
| Q4 2017 | $18,725,000 | -2.9% | 2,340,611 | -5.9% | 3.06% | +7.3% |
| Q3 2017 | $19,279,000 | +15.2% | 2,487,622 | +9.3% | 2.85% | +40.4% |
| Q2 2017 | $16,731,000 | – | 2,276,359 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |